The brand is aiming to utilise the capital for upscaling its marketing, bolstering its growth to have a pan India presence in the times ahead
TABLT is also planning to launch its first offline store in Kolkata
New Delhi, NFAPost: TABLT (previously known as Sabse Sasta Dukaan), a Bharat focussed Online Pharmacy which deals in medicines and healthcare products has recently announced the news of securing $3 million funding from Siti Cable.
Indian Cable Net Company Limited, a unit of Siti Networks has funded $3million in the ‘Series A’ funding round to TABLT. The capital will majorly be used by the brand for boosting its business development activities, driving its growth plans, and upscaling its marketing strategies so as to have a competitive edge and maintain its leading position in the market.
TABLT provides its services in Bharat (Semi-Urban & rural areas) in the states of West Bengal, Bihar, and Jharkhand &Odisha. The brand has gained prominence over the years and is known for its USP of one-day delivery of medicines in the Bharat Market.
It is also the first-ever online pharmacy to have an app version in Bengali, Odia, and Hindi languages. The organization believes that the pandemic indeed stepped in as a blessing in disguise for them as they have witnessed a positive impact on their business in the 2nd wave of coronavirus.
They share that their revenue has grown 9X times since last year. Additionally, there has been a significant rise in the number of new customers onboarded and they are aiming to make a revenue of 400 crores in the next 2 years.
Elucidating about securing the required financial assistance from Siti Group, TABLT Chief Executive Officer Anish Agarwal says TABLET is elated to have associated with Siti Group and thank them for believing in the company’s vision.
“We will be utilizing the investment to bolster our expansion plans and improve our business acquisition and development activities so as to ensure that we are always at the forefront of the industry in the markets that we are present in or are planning to foray into,” said Anish Agarwal.
Anish Agarwal said Siti Group as a brand has been a pioneer in the Indian media industry and has a good presence in semi-urban and rural markets which is the company’s key targeted area. “Apart from the monetary terms, we are also aiming at having powerful synergies with the group in the times ahead,” Anish Agarwal.
TABLT is planning to raise an additional amount of 20 crores in the next three months. The firm is already in discussions with some industry giants but prefers not to divulge the details explicitly until the deal will be sealed.
ICNCL Director Suresh Sethiya while speaking about the reasons behind investing says Bharat market is still untapped as far as online pharmacies are concerned.
“I believe that TABLT Pharmacy has the potential to grow significantly and occupy a major share in the coming years. “The huge market they are present in and their enthusiastic founding team is what attracted us and made us agree to this collaboration. “We saw huge potential in them and this nudged us to sign the deal,” said Suresh Sethiya.
TABLT’s previous investors include key names such as Vinod Dugar from RDB Group, Raj Patodia from Signum Group, Sunil Singhvi from South Handlooms, along with Manoj Mehta from MTC Group, Gunavanth Vaid from 4G Capital, Aniket Gore from Ceramet group, and Kumar Subramanium, a Global Banker.
The firm’s logistics wing FLYE so far has 400 franchises. TABLT is currently operating in four states- West Bengal, Bihar, Jharkhand & Odisha and is also planning for a pan India expansion in the next financial year. The company also hints about launching its first offline store in Kolkata soon and assures that it will share the details about the same at the right time.
TABLT is one of the most trusted online pharmacies in India dealing in medicines, OTCs, and other healthcare products. Established in 2018, the company has gained the trust of more than 1 lakh +customers by home delivering authentic medicines. The company’s sole mission is to make healthcare available and affordable to all by providing the best discounts and fast delivery. It has emerged to be a relief for patients dealing with diabetes, thyroid, hypertension, and other chronic diseases.
